Found: 9
Select item for more details and to access through your institution.
Targeting CD137 enhances the efficacy of cetuximab.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 6, p. 2668, doi. 10.1172/JCI73014
- By:
- Publication type:
- Article
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 3, p. 1066, doi. 10.1172/JCI61226
- By:
- Publication type:
- Article
Asterless is a scaffold for the onset of centriole assembly.
- Published in:
- Nature, 2010, v. 467, n. 7316, p. 714, doi. 10.1038/nature09445
- By:
- Publication type:
- Article
Targeting CD137 enhances the efficacy of cetuximab.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 351, p. 1, doi. 10.1126/scitranslmed.aae0501
- By:
- Publication type:
- Article
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 63, p. 1, doi. 10.1126/scitranslmed.3001375
- By:
- Publication type:
- Article
Q&A: Michael Bishop.
- Published in:
- Nature, 2014, v. 514, n. 7522, p. S9, doi. 10.1038/514S9a
- By:
- Publication type:
- Article